tiprankstipranks
Arca Biopharma (ABIO)
NASDAQ:ABIO

Arca Biopharma (ABIO) Ownership - Who Owns Arca Biopharma?

454 Followers

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$2397243

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,221,465Insider70.46%36,592,845
10,221,465Insider70.46%36,592,845
2,100,000Insider14.48%7,518,000
1,410,143Institution9.72%5,048,312
491,889Insider3.39%1,760,963
453,598Institution3.13%1,623,881
453,598Institution3.13%1,623,881
134,831Institution0.93%482,695
50,970Insider0.35%182,473
50,000Insider0.34%179,000

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
453,598Institution3.13%1,623,881
134,831Institution0.93%482,695
46,948Institution0.32%168,074
32,400Institution0.22%115,992
14,988Institution0.10%53,657
3,161Institution0.02%11,316
174Institution<0.01%623

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
312,166Institution2.15%555,655
141,432Institution0.97%251,749
5,162Institution0.04%18,841
4Institution<0.01%14

FAQ

Who Owns Arca Biopharma (ABIO)?
Currently, no data Available
What percentage of Arca Biopharma (ABIO) stock is held by institutional investors?
Currently, no data Available
What percentage of Arca Biopharma (ABIO) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Arca Biopharma (ABIO)?
Harry Weller owns the most shares of Arca Biopharma (ABIO).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis